Evidence map›Paper›PMID 25328682›Full record

ArticleVaccines2014

HSP70 promoter-driven activation of gene expression for immunotherapy using gold nanorods and near infrared light.

Helen A Andersson, Yoo-Shin Kim, Brian E O'Neill, Zheng-Zheng Shi, Rita E Serda

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Pulsed Electric Fields Alter Expression of NF-κB Promoter-Controlled Gene.International journal of molecular sciences · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2017
    Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Helen A AnderssonDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX.
Yoo-Shin KimDepartment of Translational Imaging, Houston Methodist Research Institute, Houston, TX.
Brian E O'NeillDepartment of Translational Imaging, Houston Methodist Research Institute, Houston, TX.
Zheng-Zheng ShiDepartment of Translational Imaging, Houston Methodist Research Institute, Houston, TX.
Rita E SerdaDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX ; Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA.
Houston Methodist · USBaylor College of Medicine · US

Funding

Texas Center for Cancer NanomedicineU54CA151668 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FERRARI, MAURO · 2010 to 2014
$12.4M
TRANS-NETWORK PROJECTSU54CA143837 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FERRARI, MAURO · 2009 to 2014
$10.8M
Inhibition of OLA1: A Novel Strategy for Anti-Metastasis TherapyR01CA155069 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI SHI, ZHENG-ZHENG · 2011 to 2015
$1.6M
NCI NIH HHS R01 CA155069NCI NIH HHS U54 CA143837NCI NIH HHS U54 CA151668
6 · The paper itself

Abstract

Modulation of the cytokine milieu is one approach for vaccine development. However, therapy with pro-inflammatory cytokines, such as IL-12, is limited in practice due to adverse systemic effects. Spatially-restricted gene expression circumvents this problem by enabling localized amplification. Intracellular co-delivery of gold nanorods (AuNR) and a heat shock protein 70 (HSP70) promoter-driven expression vector enables gene expression in response to near infrared (NIR) light. AuNRs absorb the light, convert it into heat and thereby stimulate photothermal expression of the cytokine. As proof-of-concept, human HeLa and murine B16 cancer cells were transfected with a HSP70-Enhanced Green Fluorescent Protein (EGFP) plasmid and polyethylenimine (PEI)-conjugated AuNRs. Exposure to either 42 °C heat-shock or NIR light induced significant expression of the reporter gene. In vivo NIR driven expression of the reporter gene was confirmed at 6 and 24 h in mice bearing B16 melanoma tumors using in vivo imaging and flow-cytometric analysis. Overall, we demonstrate a novel opportunity for site-directed, heat-inducible expression of a gene based upon the NIR-absorbing properties of AuNRs and a HSP70 promoter-driven expression vector.

Indexed as

cancergold nanorodHSP70 promoterimmunotherapynear infrared

Identifiers

PMID25328682
PMCPMC4199457
OpenAlexW2053056865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.